The Long Run with Luke Timmerman

Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies

Feb 14, 2023

01:11:43

Creator website

Highlights

AI Chapters

Episode notes

Cancer and the Kilimanjaro Campaign - Mission-Driven Executive

02:51

Gene Editing and X-Vivo - What's Next?

02:22

Is GBM a Good Approach?

03:21

Introduction

3min

The Long Run Podcast - Joanne Smith-Farrell

3min

Cancer and the Kilimanjaro Campaign - Mission-Driven Executive

3min

The Mountain Is a Metaphor

2min

The Immigrant Story: Your Dad Was a Physicist

3min

Is He Older or Younger Than You?

2min

What I Learned From Public School

2min

What Do You Think You're Going to Do With Your Physics Degree?

2min

What a Privilege It Was to Be a Jew

3min

10.

Biochemistry

2min

11.

The Diversity of Perspective in Bob's Teams

2min

12.

What's the Main Thing in Bob's Lab?

3min

13.

How to Outsource Life Science Research - Scientist.com

2min

14.

What I Love About Business Development

3min

15.

Gene Logic - How Did You End Up at Pfizer?

2min

16.

What Attracted You to Pfizer?

2min

17.

Is GBM a Good Approach?

3min

18.

What I've Learned From Bluebird's Death

2min

19.

Bluebird Oncology Franchise - How Did You Get Into It?

2min

20.

CAR-T Therapy

3min

21.

I've Been Following B Cells for Years

3min

22.

Gene Editing

2min

23.

T Cell Therapy

2min

24.

B-Bio Pharma - How Did That Come About?

2min

25.

Gene Editing and X-Vivo - What's Next?

2min

26.

Are You the Best Person to Lead This?

3min

27.

The Imposter Syndrome - Can I Really Do This?

2min

28.

Is There a Future in B Cell Medicine?

2min

29.

Do You Need to Redo Your B Cells?

3min

30.

Cell Therapy - What's the Difference Between T Cells and B Cells?

2min

Joanne Smith-Farrell, CEO of Cambridge, Mass.-based Be Biopharma, on Engineered B-Cell Therapies for Cancer & Rare Diseases.

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.